Agilent Technologies has launched version 1.5 of its CytoGenomics software.
The tool allows Agilent customers to analyze their comparative genomic hybridization and CGH+SNP microarray data. It also enables users to access information from the firm's in-house CytoGenomics database and external resources such as the Online Mendelian Inheritance in Man database, the Database of Genomic Variants, and Entrez.
Randox Laboratories has launched Evidence MultiStat, an automated, benchtop system. Using the new system, customers can process up to 97 drug metabolites in one patient sample on the Crumlin, UK-based firm's biochips.
According to Randox, Evidence MultiStat is intended for use in onsite drug testing. The system can also generate quality control data, the firm noted.